Over 65 Travel Insurance With Medical Conditions

Buying travel insurance with a medical condition to declare at 65 or over is a genuinely different process from buying a standard policy, involving specific screening questions that determine both eligibility and price rather than a single age-based premium. Anyone without a condition to declare should read the over 65 travel insurance guide instead, which covers healthy-traveller pricing, annual policy economics and age limits at this stage in full. This guide covers the medical screening process itself: what questions are typically asked, how answers translate into pricing, how specialist insurers compare against mainstream providers for declared conditions, and what happens if a condition is not disclosed accurately. Screening exists because travel insurers price risk individually rather than purely by age band once a medical condition is involved, which means the process, while more involved than buying a standard policy, is also the route to genuinely tailored pricing rather than a flat loading applied regardless of how well a specific condition is actually controlled.

The medical screening walkthrough at 65 and over

Medical screening for travel insurance typically takes the form of a structured set of questions covering each condition being declared: what the condition is, when it was diagnosed, what treatment or medication is currently being used, whether the condition has required hospital admission or a change in treatment within a defined recent period, commonly the last twelve months, and whether the policyholder is currently fit to travel and undertake the specific activities planned on the trip. Insurers use these answers to build a risk assessment for that specific condition rather than applying a single blanket loading for having any medical history at all, which is why two policyholders with different conditions, or even the same condition at different stages of control, can receive meaningfully different quotes from the same insurer. An estimated one in three travellers aged 65 and over declares at least one medical condition when buying travel insurance, based on industry estimates drawing on ABI and ONS data on health prevalence in this age group, which makes the screening process a routine part of buying cover for a substantial share of this age band rather than an unusual exception. Screening is usually completed through an online questionnaire or a phone-based screening call, and both routes ask broadly the same underlying questions, though a phone screening allows more back-and-forth clarification on borderline answers than a fixed online form typically permits, which can matter for a condition that does not map neatly onto a standard question. Some insurers also ask about planned activities during the trip specifically in relation to a declared condition, since an activity that would be unremarkable for a healthy traveller, such as a long hiking day or a high-altitude excursion, can interact with a declared condition in ways that affect both eligibility and pricing, making it worth declaring planned activities accurately alongside medical history rather than treating the two as separate questions.

How declared conditions affect price

The price impact of a declared condition varies enormously depending on the specific condition, how well controlled it is, and how recently it has required medical intervention, which makes a single average figure of limited use to any individual policyholder. Well-controlled, stable conditions with no recent hospital admission or medication change, such as managed high blood pressure or long-stable diabetes, commonly add a modest premium loading, often in a range comparable to the general age-based uplift already applied at this age, based on current provider disclosures. Conditions involving recent treatment changes, a recent diagnosis, or a history requiring hospital admission within the past year tend to carry a more substantial loading, and some conditions, particularly certain cancers within an active treatment window or very recently diagnosed serious conditions, may be declined by mainstream insurers entirely and require a specialist provider experienced in underwriting that specific condition. Getting a quote directly, rather than estimating from a general range, is the only way to establish the actual price impact for a specific declared condition, since the variation between conditions and between insurers is too wide for a general figure to be a reliable guide for an individual case. Multiple declared conditions are also common at this age and are generally assessed together rather than each condition simply adding a separate, stackable loading, since an insurer's overall risk assessment considers how conditions interact rather than treating each one in complete isolation, which is part of why two policyholders each declaring the same two conditions individually can still see different combined pricing depending on the specific pairing and how those conditions are understood to interact clinically.

Specialists versus mainstream insurers at this age

Insurers such as AllClear, InsuranceWith and Staysure specialise specifically in medical travel insurance underwriting, and this specialism generally shows up as more favourable pricing and a wider range of conditions accepted compared with a mainstream general insurer's medical add-on process. Mainstream insurers typically apply a more generalised screening process not built primarily around complex medical cases, which can mean higher loadings, a narrower range of accepted conditions, or outright decline for conditions a dedicated specialist would price and accept as a matter of routine business. This does not mean a specialist is automatically cheaper for every condition and every policyholder, since pricing still varies by the specific condition and its current status, but for anyone with a condition beyond the most straightforward and well controlled, comparing a specialist quote against a mainstream quote directly, rather than assuming either category is automatically better value, is worth the extra step before choosing a provider. Specialist insurers also tend to have clearer, more detailed screening processes specifically because complex medical cases are their core business rather than an occasional add-on, which can mean a more thorough set of questions but also a more accurate resulting price, since the insurer's underwriting is built around handling exactly this kind of case rather than a generalised process adapted from standard travel cover.

Non-disclosure consequences

Failing to declare a relevant medical condition, whether through oversight or a judgement that it did not seem significant enough to mention, carries real consequences at claim time that go beyond the specific condition omitted. An insurer that discovers an undisclosed condition relevant to a claim can decline that claim, and in more serious cases of clear non-disclosure can void the policy entirely, which can leave a policyholder liable for medical costs abroad that would otherwise have been covered. The Financial Ombudsman Service assesses non-disclosure disputes on whether the information withheld was information a reasonable policyholder would have understood to be relevant to the insurer's screening questions, rather than applying a blanket rule that any omission voids a policy automatically, which means a genuinely accidental and minor omission is assessed differently from a clear and material failure to disclose a relevant condition. This distinction does not make full and accurate disclosure any less important at the point of purchase, since a policyholder cannot know in advance how a dispute would be assessed, but it is useful context for understanding that the ombudsman's approach is not purely mechanical. Reviewing and re-declaring medical information at every renewal or new policy purchase, rather than relying on a previous year's declaration or assuming a minor change does not need reporting, remains the most reliable way to avoid a non-disclosure dispute arising in the first place, since even a small change in medication or a new diagnosis since the last policy can be relevant to an insurer's current risk assessment even where it was not relevant at the time of a previous declaration.

Cancer and diabetes: condition-specific cover

Certain conditions come up often enough in this age band to warrant their own dedicated guidance beyond the general screening process described above. Cancer diagnoses, whether recent, in active treatment, or in long-term remission, involve their own specific screening questions and specialist provider landscape, covered in full in the cancer travel insurance comparison. Diabetes, one of the most commonly declared conditions across this age band generally, similarly has its own typical pricing pattern and provider comparison worth reading in full at the diabetes travel insurance guide, rather than repeated in summary form here. Both guides sit within the same broader pre-existing medical conditions coverage this site maintains, which is worth a wider read for anyone managing more than one declared condition at once. Reading the condition-specific guide relevant to a particular diagnosis, rather than relying on the general screening description above alone, generally gives a clearer sense of what to expect from a specific insurer's questions and pricing pattern, since cancer and diabetes each have screening nuances, such as time-since-treatment thresholds for cancer or insulin-dependency questions for diabetes, that a general overview of medical screening cannot cover in the same depth as a guide built around that specific condition.

What the data shows

Figures in this guide on condition prevalence and pricing reflect a mix of provider disclosures and industry estimates drawing on ABI and ONS data, since no single published dataset tracks premium impact by specific condition across the whole UK market, and insurers generally treat their own detailed underwriting criteria for specific conditions as commercially sensitive rather than publishing it in a directly comparable form. The Financial Ombudsman Service's published approach to non-disclosure disputes, and the Financial Conduct Authority's Consumer Duty rules requiring fair value and clear communication from insurers, both apply directly to how medical screening and pricing are expected to be conducted:

• An estimated one in three travellers aged 65 and over declares at least one medical condition when buying travel insurance.
• Well-controlled, stable conditions typically carry a modest premium loading, while recent diagnoses or hospital admissions carry a more substantial one.
• Specialist insurers including AllClear, InsuranceWith and Staysure generally accept a wider range of conditions than mainstream general insurers.
• The Financial Ombudsman Service assesses non-disclosure disputes on whether withheld information was reasonably understood to be relevant, rather than applying a blanket rule.

Frequently asked questions

What questions does travel insurance medical screening ask?

Screening asks a structured set of questions per condition: what it is, when diagnosed, current treatment and medication, whether it has required hospital admission or a treatment change within a recent period, commonly twelve months, and whether the applicant is fit to travel for the specific trip planned. Some insurers also ask about planned activities in relation to declared conditions. Answers build an individual risk assessment rather than a blanket loading, which is why the same condition at different stages of control can price differently, and why having medication lists and dates to hand before starting produces a more accurate quote.

How much does a declared condition add to the premium?

It varies too widely for a single figure to be reliable. Well-controlled stable conditions, such as managed blood pressure or long-stable diabetes, commonly add a modest loading comparable to the general age uplift. Recent diagnoses, treatment changes or hospital admissions within the past year carry more substantial loading, and some conditions in active treatment windows may be declined by mainstream insurers and need a specialist. Getting direct quotes is the only reliable way to establish the impact for a specific condition, and comparing a specialist against a mainstream quote is worth the extra step.

Are specialist medical travel insurers cheaper than mainstream ones?

Often, for anything beyond the most straightforward conditions, though not automatically for every case. AllClear, InsuranceWith and Staysure underwrite complex medical cases as core business, which generally shows as wider condition acceptance and more favourable pricing for declared conditions than a mainstream insurer's generalised medical add-on process. Mainstream insurers can remain competitive for a single well-controlled condition. The reliable approach is one quote from each category compared directly, since the gap between the two is largest exactly where the medical history is most complex.

What happens if I forget to declare a condition?

An insurer discovering an undisclosed relevant condition at claim time can decline that claim, and in serious cases void the policy entirely, potentially leaving the policyholder liable for medical costs abroad. The Financial Ombudsman Service assesses disputes on whether the withheld information was something a reasonable policyholder would have understood as relevant to the screening questions, rather than voiding automatically for any omission, so a genuinely minor accidental omission is assessed differently from a material non-disclosure. Full declaration at purchase, and re-declaration at every renewal, remains the only reliable protection.

Do I need to re-declare my conditions every year?

Yes, effectively. A renewal or new policy needs the medical picture as it stands now, not as declared a year earlier, and any new diagnosis, medication change or hospital contact since the last declaration needs adding regardless of how minor it seems. Insurers assess relevance against their current screening criteria, and an outdated declaration carries the same non-disclosure risk as an incomplete new one. Treating the renewal screening as a fresh declaration, checked against current prescriptions and recent medical correspondence rather than memory, is the safest routine from this age onward.